Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.
Saved in:
| Title: | Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials. |
|---|---|
| Authors: | Post, Frank A1 (AUTHOR), Wohl, David2 (AUTHOR), Liegeon, Geoffroy3 (AUTHOR), Brar, Indira4 (AUTHOR), Hagins, Debbie5 (AUTHOR), Yazdanpanah, Yazdan6 (AUTHOR), Avihingsanon, Anchalee7 (AUTHOR), Liu, Hui8 (AUTHOR), Aizen, Keith8 (AUTHOR), Hindman, Jason T8 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. May2026, Vol. 13 Issue 5, p1-4. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
